Literature DB >> 20869886

Impact of the lung allocation score on resource utilization after lung transplantation in the United States.

George J Arnaoutakis1, Jeremiah G Allen, Christian A Merlo, Brigitte E Sullivan, William A Baumgartner, John V Conte, Ashish S Shah.   

Abstract

BACKGROUND: The United States lung allocation score (LAS) allows rapid organ allocation to higher acuity patients. Although, wait-list time and wait-list mortality have improved, the costs of lung transplantation (LTx) in these higher acuity patients are largely unknown. We hypothesize that LTx in high LAS recipients is associated with increased charges and resource utilization.
METHODS: Clinical and financial data for LTx patients at our institution in the post-LAS era (May 2005 to 2009) were reviewed with follow-up through December 2009. Patients were stratified by LAS quartiles (Q). Total hospital charges for index admission and all admissions within 1 year of LTx were compared between Q4 vs Q1-3 using rank-sum and Kruskal-Wallis tests, as charge data were not normally distributed.
RESULTS: Eighty-four LTxs were performed during the study period. Sixty-three (75%) patients survived 1 year; 10 (11.9%) died during the index admission. Median LAS was 37.5 (interquartile range [IQR] 34.3 to 44.8). LAS quartiles were: Q1, 30.1 to 34.3, n = 21; Q2, 34.4 to 37.5, n = 21; Q3, 37.6 to 44.8, n = 21; and Q4, 44.9 to 94.3, n = 21. Charges for index admission were: Q4, $276,668 (IQR 191,301 to 300,156) vs Q1-3, $153,995 (IQR 129,796 to 176,849) (p < 0.001). Index admission median length of stay was greater in Q4 (Q4: 35-day IQR 23 to 46 vs Q1-3: 15-day IQR 11 to 22, p = 0.003). For 1-year charges: Q4, $292,247 (IQR 229,192 to 421,597) vs Q1-3, $188,342 (IQR 153,455 to 252,045) (p = 0.002). Index admission and 1-year charges in Q4 were higher than for other quartiles when examined individually.
CONCLUSIONS: This is the first study to show increased charges in high LAS patients. Charges for the index admission and hospital care in the year post-LTx were higher in the highest LAS quartile compared with patients in the lowest 75% of LAS.
Copyright © 2011 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20869886      PMCID: PMC3132211          DOI: 10.1016/j.healun.2010.06.018

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  10 in total

1.  High lung allocation score is associated with increased morbidity and mortality following transplantation.

Authors:  Mark J Russo; Alexander Iribarne; Kimberly N Hong; Ryan R Davies; Steve Xydas; Hiroo Takayama; Ali Ibrahimiye; Annetine C Gelijns; Matthew D Bacchetta; Frank D'Ovidio; Selim Arcasoy; Joshua R Sonett
Journal:  Chest       Date:  2009-10-09       Impact factor: 9.410

2.  Survival after single versus bilateral lung transplantation for high-risk patients with pulmonary fibrosis.

Authors:  Eric S Weiss; Jeremiah G Allen; Christian A Merlo; John V Conte; Ashish S Shah
Journal:  Ann Thorac Surg       Date:  2009-11       Impact factor: 4.330

3.  Cost-utility of lung transplantation: a pilot study.

Authors:  S H Gartner; M A Sevick; R J Keenan; G J Chen
Journal:  J Heart Lung Transplant       Date:  1997-11       Impact factor: 10.247

4.  An economic evaluation of lung transplantation.

Authors:  Ani C Anyanwu; Alistair McGuire; Chris A Rogers; Andrew J Murday
Journal:  J Thorac Cardiovasc Surg       Date:  2002-03       Impact factor: 5.209

5.  A cost-effectiveness and cost-utility study of lung transplantation.

Authors:  Helen-Maria Vasiliadis; Jean-Paul Collet; John R Penrod; Pasquale Ferraro; Charles Poirier
Journal:  J Heart Lung Transplant       Date:  2005-09       Impact factor: 10.247

6.  Development of the new lung allocation system in the United States.

Authors:  T M Egan; S Murray; R T Bustami; T H Shearon; K P McCullough; L B Edwards; M A Coke; E R Garrity; S C Sweet; D A Heiney; F L Grover
Journal:  Am J Transplant       Date:  2006       Impact factor: 8.086

7.  Cost of acute renal replacement therapy in the intensive care unit: results from The Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) study.

Authors:  Nattachai Srisawat; Loredo Lawsin; Shigehiko Uchino; Rinaldo Bellomo; John A Kellum
Journal:  Crit Care       Date:  2010-03-26       Impact factor: 9.097

8.  Lung allocation score predicts survival in lung transplantation patients with pulmonary fibrosis.

Authors:  Eric S Weiss; Jeremiah G Allen; Christian A Merlo; John V Conte; Ashish S Shah
Journal:  Ann Thorac Surg       Date:  2009-12       Impact factor: 4.330

9.  Impact of U.S. Lung Allocation Score on survival after lung transplantation.

Authors:  Christian A Merlo; Eric S Weiss; Jonathan B Orens; Marvin C Borja; Marie Diener-West; John V Conte; Ashish S Shah
Journal:  J Heart Lung Transplant       Date:  2009-08       Impact factor: 10.247

10.  The cost-effectiveness of lung transplantation. A pilot study. University of Washington Medical Center Lung Transplant Study Group.

Authors:  S D Ramsey; D L Patrick; R K Albert; E B Larson; D E Wood; G Raghu
Journal:  Chest       Date:  1995-12       Impact factor: 9.410

  10 in total
  12 in total

1.  Society of Thoracic Surgeons Risk Score predicts hospital charges and resource use after aortic valve replacement.

Authors:  George J Arnaoutakis; Timothy J George; Diane E Alejo; Christian A Merlo; William A Baumgartner; Duke E Cameron; Ashish S Shah
Journal:  J Thorac Cardiovasc Surg       Date:  2011-04-17       Impact factor: 5.209

2.  Increased resource use in lung transplant admissions in the lung allocation score era.

Authors:  Bryan G Maxwell; Joshua J Mooney; Peter H U Lee; Joseph E Levitt; Laveena Chhatwani; Mark R Nicolls; Martin R Zamora; Vincent Valentine; David Weill; Gundeep S Dhillon
Journal:  Am J Respir Crit Care Med       Date:  2015-02-01       Impact factor: 21.405

3.  General and acute care surgical procedures in patients with left ventricular assist devices.

Authors:  George J Arnaoutakis; Gregory J Bittle; Jeremiah G Allen; Eric S Weiss; Jennifer Alejo; William A Baumgartner; Ashish S Shah; Christopher L Wolfgang; David T Efron; John V Conte
Journal:  World J Surg       Date:  2014-04       Impact factor: 3.352

4.  Human leukocyte antigens antibodies after lung transplantation: Primary results of the HALT study.

Authors:  Ramsey R Hachem; Malek Kamoun; Marie M Budev; Medhat Askar; Vivek N Ahya; James C Lee; Deborah J Levine; Marilyn S Pollack; Gundeep S Dhillon; David Weill; Kenneth B Schechtman; Lorriana E Leard; Jeffrey A Golden; LeeAnn Baxter-Lowe; Thalachallour Mohanakumar; Dolly B Tyan; Roger D Yusen
Journal:  Am J Transplant       Date:  2018-05-15       Impact factor: 8.086

5.  Severe acute kidney injury according to the RIFLE (risk, injury, failure, loss, end stage) criteria affects mortality in lung transplantation.

Authors:  George J Arnaoutakis; Timothy J George; Chase W Robinson; Kevin W Gibbs; Jonathan B Orens; Christian A Merlo; Ashish S Shah
Journal:  J Heart Lung Transplant       Date:  2011-05-28       Impact factor: 10.247

6.  Interim report of the Japanese original donor evaluation and management system: the medical consultant system.

Authors:  Tomoyuki Nakagiri; Masayoshi Inoue; Masato Minami; Yasushi Hoshikawa; Masayuki Chida; Toru Bando; Takahiro Oto; Takeshi Shiraishi; Naoya Yamasaki; Juntaro Ashikari; Yoshiki Sawa; Meinoshin Okumura
Journal:  Surg Today       Date:  2014-07       Impact factor: 2.549

7.  Delirium After Spine Surgery in Older Adults: Incidence, Risk Factors, and Outcomes.

Authors:  Charles H Brown; Andrew LaFlam; Laura Max; Julie Wyrobek; Karin J Neufeld; Khaled M Kebaish; David B Cohen; Jeremy D Walston; Charles W Hogue; Lee H Riley
Journal:  J Am Geriatr Soc       Date:  2016-10-03       Impact factor: 5.562

8.  The Impact of Delirium After Cardiac Surgical Procedures on Postoperative Resource Use.

Authors:  Charles H Brown; Andrew Laflam; Laura Max; Daria Lymar; Karin J Neufeld; Jing Tian; Ashish S Shah; Glenn J Whitman; Charles W Hogue
Journal:  Ann Thorac Surg       Date:  2016-03-31       Impact factor: 4.330

9.  Is SAPS 3 better than APACHE II at predicting mortality in critically ill transplant patients?

Authors:  Vanessa M de Oliveira; Janete S Brauner; Edison Rodrigues Filho; Ruth G A Susin; Viviane Draghetti; Simone T Bolzan; Silvia R R Vieira
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

10.  Influence on ICU course, outcome and costs for lung transplantation after implementation of the new Swiss transplantation law.

Authors:  Stephanie Klinzing; Giovanna Brandi; Dimitri A Raptis; Urs Wenger; Denise Weber; Paul A Stehberger; Ilhan Inci; Markus Béchir
Journal:  Transplant Res       Date:  2014-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.